We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Injectable Cardiac Monitor Facilitates Arrhythmia Detection

By HospiMedica International staff writers
Posted on 16 Jul 2019
A novel injectable cardiac monitor (ICM) documents suspected arrhythmia or unexplained syncope, enabling faster diagnosis and appropriate treatment.

The BIOTRONIK (Buelach, Switzerland) Biomonitor III ICM is a remote monitor designed for highly accurate and reliable continuous detection of cardiac electrical events. More...
The ICM comes pre-assembled in a one-piece injection tool device, which implants it under the skin with a very small incision, facilitating in-office treatments. The ICM comes fully integrated with the fully automatic, daily remote monitoring system developed specially for ICM devices, BIOTRONIK Home Monitoring. Due to automatic pairing, initialization, and data transmission no active patient involvement is required.

Biomonitor III also features BIOvector, a unique hybrid rigid-flexible footprint designed to improve sensing without sacrifice to patient comfort or cosmetic appearance, including a small and flexible sensing antenna. Biomonitor III also utilizes a lossless compression algorithm to ensure that high amplitude signal quality is available via the Home Monitoring system. Intelligent memory management prevents overwriting clinically relevant episodes in order to improve diagnostic workflow performance. In addition, a patient engagement app annotates symptoms, with automatic synchronization to BIOTRONIK Home Monitoring.

“This device maintains exceptional functionality in detecting arrhythmia, and its reduced size and novel delivery tool simplifies the injection procedure,” said Ryan Walters, President of BIOTRONIK. “Physicians and patients can count on Biomonitor III to deliver timely and accurate data to identify potentially life-threatening cardiac arrhythmias faster and more confidently than ever before.”

“Biomonitor ICMs have a proven track record for exceptional signal quality. Biomonitor III expands the existing diagnostic utility of these devices while simplifying the procedure,” said Raul Weiss, MD, of Columbus (OH, USA). “Biomonitor III is an exceedingly small device with market-leading four year longevity. When physicians are not burdened by poor signal quality, clinically irrelevant data, inaccurate, or worse, missed detections, more time can be devoted to ensuring a timely and accurate diagnosis.”

Biomonitor III is approved as magnetic resonance (MR) conditional for both 1.5T and 3.0T applications.



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Cardiograph Device
PageWriter TC35
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.